[Polaris Group] Announcement Regarding the Change of Director at Subsidiary, LianYang Pharma
Polaris Group announced a change of director at its subsidiary, LianYang Pharma. Mr. Chen Hong-wen has resigned, and Mr. Hou Yu-hsiang has been appointed as his successor, effective upon parent company reallocation.
📋 Article Processing Timeline
- 📰 Published: May 25, 2026 at 09:00
- 🔍 Collected: May 26, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 26, 2026 at 08:46 (46 min after Collected)
1. Date of change: 2026/05/25
2. Personnel category: Natural person director
3. Name and title of predecessor: Chen Hong-wen, Director of LianYang Pharma
4. Profile of predecessor: Director of LianYang Pharma
5. Name and title of successor: Hou Yu-hsiang, Director of LianYang Pharma
6. Profile of successor: Human Resources Director at LianYang Biopharma
7. Type of change: Resignation
8. Reason for change: Reallocation by the parent company
9. Shareholding at time of appointment: Not applicable
10. Original term: Not applicable
11. Effective date: Not applicable
12. Change ratio of directors for the same term: Not applicable
13. Change ratio of independent directors for the same term: Not applicable
14. Change ratio of supervisors for the same term: Not applicable
15. Whether changes involve more than one-third of directors: No
16. Other notes: None
2. Personnel category: Natural person director
3. Name and title of predecessor: Chen Hong-wen, Director of LianYang Pharma
4. Profile of predecessor: Director of LianYang Pharma
5. Name and title of successor: Hou Yu-hsiang, Director of LianYang Pharma
6. Profile of successor: Human Resources Director at LianYang Biopharma
7. Type of change: Resignation
8. Reason for change: Reallocation by the parent company
9. Shareholding at time of appointment: Not applicable
10. Original term: Not applicable
11. Effective date: Not applicable
12. Change ratio of directors for the same term: Not applicable
13. Change ratio of independent directors for the same term: Not applicable
14. Change ratio of supervisors for the same term: Not applicable
15. Whether changes involve more than one-third of directors: No
16. Other notes: None
FAQ
What is the reason for the personnel change at Polaris Group's subsidiary?
It is due to a replacement by the parent company, Polaris Group.
Will this change affect the management strategy?
It is part of the group's overall personnel optimization and does not indicate a major policy shift.